An experimental murine anti-MPO model further showed that lipopolysaccharide (LPS) can synergize with anti-MPO autoimmunity, exacerbating the NCGN disease phenotype (44). Collectively, these findings suggest that infection and innate immune activation can amplify the anti-MPO driven autoimmunity. This evidence concerns the gene MPO and Autoimmunity.